Fate Therapeutics, Inc.

FATE us
$2.35
▲ +0.02 (+0.86%)
Volume: 3,385,989 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 41
  • 21d momentum -8.6%
  • RSI 43
🎯 Pullback 62
  • Near lower Bollinger band
  • -3.3% vs 20MA
💎 Value 58
  • -27% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)43.3
MACD-0.002
MA trendMixed
ATR6.44%
21d mom.-8.6%
63d mom.+11.9%
vs 20MA-3.3%
RVOL(20)2.46×
52w low · 1 52w high · 3
-27.2% from 52-week high
20d support 2 · resistance 3

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$279M
PER—
PBR1.82
PSR43.01
EPS$-1.05
ROE-82.1%
ROA-48.4%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-2.03
week1M3M6M1YYTD
-7.11% -8.56% +11.90% +91.06% +132.67% +138.24%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
4/10
🐻 Bear
8/10

14d momentum -5.24%, daily vol 3.15%. Fate Therapeutics, Inc. sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.